Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-02

FDA Approved: LABETALOL HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original generic application for labetalol hydrochloride, with Amneal Pharmaceuticals LLC as the sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Labetalol Hydrochloride (Labetalol hydrochloride)

Snippet

ORIG AP for LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)